Comments
Loading...

Global X Genomics & Biotechnology ETF

GNOMNASDAQ
Logo brought to you by Benzinga Data
$11.35
-0.09-0.79%
At Close: -
$11.30
-0.05-0.44%
After Hours: 5:22 PM EDT
15 minutes delayed
Sector
Healthcare
Region
US
AUM
83.48M
Fund Score

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Quotes, Forecast and News Summary

Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) stock price, news, charts, stock research, profile.

Open$11.42
High$11.65
52 Wk High$12.53
AUM83.48M
Dividend-
Ex-Div Date-
Volume12.2K
Market Cap$14.08B
Mgmt Fee0.5%
P/E Ratio38.23
Prev. Close$11.44
Low$11.35
52 Wk Low$8.63
Shares Out9.12M
Yield-
Div. Freq-
Avg. Volume Daily59.68K
Beta1.11
Avg. Expense Ratio0.5%
P/B Ratio3.38

FAQ

Q

How do I buy Global X Genomics & Biotechnology ETF (GNOM) stock?

A

You can purchase shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Global X Genomics & Biotechnology ETF (GNOM) competitors?

A

There are no as such competitors for Global X Genomics & Biotechnology ETF.

Q

What is the forecast, or price target, for Global X Genomics & Biotechnology ETF (GNOM) stock?

A

There is no analysis for Global X Genomics & Biotechnology ETF to provide a consensus price target.

Q

What is the current price for Global X Genomics & Biotechnology ETF (GNOM)?

A

The stock price for Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) is $11.3 last updated September 18, 2024 at 5:22 PM EDT.

Q

Does Global X Genomics & Biotechnology ETF (GNOM) pay a dividend?

A

There are no upcoming dividends for Global X Genomics & Biotechnology ETF.

Q

When is Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) reporting earnings?

A

Global X Genomics & Biotechnology ETF does not have any upcoming earnings scheduled.

Q

Is Global X Genomics & Biotechnology ETF (GNOM) going to split?

A

There is no upcoming split for Global X Genomics & Biotechnology ETF.

ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleMid Cap Growth
Fund InceptionApr 5, 2019
Managers
Vanessa Yang
Sandy Lu
Wayne Xie
Nam To
DefinitionMost of the stocks in this Equity Fund have average financial performance and average growth potential
Investment Policy
The Fund invests at least 80 percent of its total assets in the securities of the Solactive Genomics Index (Underlying Index). The Fund's 80 percent investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received).
Top ETF Holdings
SymbolNameShare %
ALNYAlnylam Pharmaceutical...5.66%
RNAAvidity Biosciences In...5.52%
TECHBio-Techne Corp4.41%
LEGNLegend Biotech Corp4.29%
ARWRArrowhead Pharmaceutic...4.22%
NTLAIntellia Therapeutics ...4.19%
MYGNMyriad Genetics Inc4.08%
SRPTSarepta Therapeutics I...3.94%
NTRANatera Inc3.84%
MRNAModerna Inc3.76%